Former Executive Vice President, U.S. Pet Health and Commercial Operations · Elanco Animal Health Inc (ELAN)

Joyce Lee

FY2021 is the first fiscal year CompBrief holds for Joyce Lee as a named executive officer of Elanco Animal Health; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$3,179,852

Salary $551,000Stock awards $1,143,023

4th of 5 named executive officers at Elanco Animal Health by FY2021 total.

5 named officers on file for Elanco Animal Health, FY2021

Joyce Lee’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 2 equity grants, each cited to its filing
  • ELAN’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Elanco Animal Health’s whole pay program stands against its peers

  • Elanco Animal Health’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ELAN→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 6, 2022 (DEF 14A).

Free

Get Joyce Lee’s full pay file as a PDF — free

More than this page: up to 10 years of Joyce’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Joyce Lee compensation by year

Elanco Animal Health Summary Compensation Table · the one fiscal year held
In US dollars, as Elanco Animal Health reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$551,000
Bonus$0
Stock awards$1,143,023
Option awards$0
Non-equity incentive$509,124
Pension and deferred compensation$0
All other$976,705
Total$3,179,852

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Elanco Animal Health Inc DEF 14A filed April 6, 2022, accession 0001140361-22-013379, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Elanco Animal Health Inc filed document, accession 0001140361-22-013379. Every figure is read from that document and cited to the page and table it appears in. Filed April 6, 2022.

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU12,738$361,504—

Per the Outstanding Equity Awards at Fiscal Year-End table in Elanco Animal Health Inc's FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Elanco Animal Health’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Jeffrey SimmonsPresident and CEO$12,060,015
Aaron SchachtFormer Executive Vice President , Innovation , Regulatory and Business Development$4,117,970
Todd YoungExecutive Vice President and Chief Financial Officer$3,291,910
Joyce Lee · this pageFormer Executive Vice President, U.S. Pet Health and Commercial Operations$3,179,852
Ramiro CabralExecutive Vice President and President, Elanco International$2,220,146

The full Elanco Animal Health compensation record

free company brief

This page is one person within Elanco Animal Health's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Elanco Animal Health proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Elanco Animal Health's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Joyce Lee's compensation dossier · One-time report. No refunds.